EpiScreen® 2.0 Time Course Assay: A Sensitive & Data-Rich Tool for Pre-Clinical Immunogenicity Testing of Biologic

Access our latest poster from AAPS PharmSci360 entitled, ‘EpiScreen® 2.0 Time Course Assay: A Sensitive & Data-Rich Tool for Pre-Clinical Immunogenicity Testing of Biologic’.

The purpose of this study was to develop a next-generation immunogenicity assay that does not compromise sensitivity, while delivering data on specificity and mechanism of action. The result is an improved assay which increases confidence in preclinical immunogenicity risk assessment data and lead selection.

Avoid issues later in the drug development process, start smart with EpiScreen® 2.0.

Poster authors include: Mercedes Perez-Olivares, Beverley Campbell, Edward Cloake, Erika Kovacs, Rob Holgate & Campbell Bunce.

To find out our conclusions, download our scientific poster today to learn more. If you have any questions for our team of experts please contact us.

Download Poster